mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.6 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |